Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810207 | PMC |
| http://dx.doi.org/10.1007/s10067-021-06041-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Factors affecting hormonal outcomes in patients undergoing surgery for non-functioning pituitary neuroendocrine tumors: a prospective observational study.
Neurosurg Rev
December 2024
Department of Neurosurgery, Sawai Man Singh Medical College, Jaipur, Rajasthan, 302004, India.
Surgical resection of non-functioning pituitary neuroendocrine tumors (NF-PitNET) is associated with new onset hormonal axis (HA) dysfunction, and factors predicting HA dysfunction are controversial, especially in large and giant NF-PitNET. Thus, we evaluated the postoperative hormonal function and assessed factors affecting HA dysfunction in patients with NF-PitNET. This prospective observational study involved 50 patients who underwent endoscopic surgical resection of NF-PitNET in the Department of Neurosurgery (April 2023-March 2024).
View Article and Find Full Text PDFDiagnostic performance of a newly launched Canadian fast-track ultrasound clinic by rheumatologists for the diagnosis of giant cell arteritis.
Int J Qual Health Care
November 2024
Faculty of Medicine, Université de Montréal, 2900 Blvd Edouard Montpetit, Montreal, Quebec H3T 1J4, Canada.
Article Synopsis
- Giant cell arteritis (GCA) is a serious condition that can be difficult to diagnose, making early detection crucial to prevent complications; recent guidelines recommend temporal artery biopsy or ultrasound for confirmation.
- This study evaluated the effectiveness of a fast-track ultrasound clinic run by trained rheumatologists in diagnosing GCA by analyzing data from 99 patient visits between 2020 and 2022.
- Results showed that temporal artery ultrasound had a high sensitivity (86.3%) and specificity (90.9%), indicating it could be a reliable alternative to biopsy for diagnosing GCA in the fast-track setting.
Serial assessment of ultrasound sensitivity and scores in patients with giant cell arteritis before and 3 and 10 days after treatment.
Rheumatology (Oxford)
October 2024
Department of Medicine, The Regional Hospital in Horsens, Horsens, Denmark.
Article Synopsis
- The study aimed to assess the effectiveness of vascular ultrasound (US) in detecting giant cell arteritis (GCA) before and after starting glucocorticoid (GC) treatment in patients new to the condition.
- A total of 48 treatment-naïve patients underwent various imaging tests, and US sensitivity showed high initial rates, followed by a decrease in sensitivity at days 3 and 10 after GC treatment, particularly for temporal artery (TA) assessments.
- Findings suggest a rapid reduction in vasculitic signs after 3 days of treatment, emphasizing the need for early US evaluation within this timeframe to ensure accurate GCA diagnosis.
Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic.
Rheumatology (Oxford)
September 2024
Department of Rheumatology, Tallaght University Hospital, Dublin, Ireland.
Article Synopsis
- The study investigates the effectiveness of a fast-track clinic for early diagnosis and treatment of polymyalgia rheumatica (PMR), aiming to analyze patient and disease characteristics in new cases.
- Over 12 months, 172 patients were referred, revealing that 39% had alternative diagnoses, and 75% experiencing adverse effects from glucocorticoid treatment.
- The findings advocate for delaying glucocorticoid therapy until specialist evaluation, highlighting the need for fast-track clinics to improve diagnosis and patient care.
Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms.
Autoimmun Rev
September 2024
Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address:
Introduction: An altered immune tolerance disturbed by immune checkpoint inhibitors (ICIs) may contribute to new-onset polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). This systematic literature review (SLR) examines the characteristics of PMR and GCA-like syndromes following anticancer treatment with ICIs, summarizing their demographic, clinical and treatment-related features to provide insights whether they differ from the idiopathic forms.
Methods: The SLR was conducted in Medline and EMBASE databases from inception to July 2024, and in the EULAR/ACR abstract database (2021-2023).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!